These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24176494)

  • 61. Response to primary and booster vaccination with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in Korean infants.
    Kim CH; Kim JS; Cha SH; Kim KN; Kim JD; Lee KY; Kim HM; Kim JH; Hyuk S; Hong JY; Park SE; Kim YK; Kim NH; Fanic A; Borys D; Ruiz-Guiñazù J; Moreira M; Schuerman L; Kim KH
    Pediatr Infect Dis J; 2011 Dec; 30(12):e235-43. PubMed ID: 21817957
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.
    Dagnew AF; Ilhan O; Lee WS; Woszczyk D; Kwak JY; Bowcock S; Sohn SK; Rodriguez Macías G; Chiou TJ; Quiel D; Aoun M; Navarro Matilla MB; de la Serna J; Milliken S; Murphy J; McNeil SA; Salaun B; Di Paolo E; Campora L; López-Fauqued M; El Idrissi M; Schuind A; Heineman TC; Van den Steen P; Oostvogels L;
    Lancet Infect Dis; 2019 Sep; 19(9):988-1000. PubMed ID: 31399377
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemia.
    Hagerman A; Posfay-Barbe KM; Grillet S; Ochs MM; Brookes RH; Greenberg D; Givon-Lavi N; Dagan R; Siegrist CA
    Clin Microbiol Infect; 2012 Aug; 18(8):756-62. PubMed ID: 21851490
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.
    Schwarz TF; Flamaing J; Rümke HC; Penzes J; Juergens C; Wenz A; Jayawardene D; Giardina P; Emini EA; Gruber WC; Schmoele-Thoma B
    Vaccine; 2011 Jul; 29(32):5195-202. PubMed ID: 21619909
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults.
    Rabian C; Tschöpe I; Lesprit P; Katlama C; Molina JM; Meynard JL; Delfraissy JF; Chêne G; Lévy Y;
    Clin Infect Dis; 2010 Apr; 50(8):1174-83. PubMed ID: 20210645
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
    Sen G; Chen Q; Snapper CM
    Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.
    Harrer T; Plettenberg A; Arastéh K; Van Lunzen J; Fätkenheuer G; Jaeger H; Janssens M; Burny W; Collard A; Roman F; Loeliger A; Koutsoukos M; Bourguignon P; Lavreys L; Voss G
    Vaccine; 2014 May; 32(22):2657-65. PubMed ID: 24144472
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model.
    Verhoeven D; Xu Q; Pichichero ME
    Vaccine; 2014 May; 32(26):3205-10. PubMed ID: 24731814
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.
    Roman F; Vaman T; Gerlach B; Markendorf A; Gillard P; Devaster JM
    Vaccine; 2010 Feb; 28(7):1740-5. PubMed ID: 20034605
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
    Xu Q; Surendran N; Verhoeven D; Klapa J; Ochs M; Pichichero ME
    Vaccine; 2015 Feb; 33(8):993-1000. PubMed ID: 25597944
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genetic conjugation of components in two pneumococcal fusion protein vaccines enhances paediatric mucosal immune responses.
    Pope C; Oliver EH; Ma J; Langton Hewer C; Mitchell TJ; Finn A
    Vaccine; 2015 Mar; 33(14):1711-8. PubMed ID: 25698489
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.
    Abraham S; Juel HB; Bang P; Cheeseman HM; Dohn RB; Cole T; Kristiansen MP; Korsholm KS; Lewis D; Olsen AW; McFarlane LR; Day S; Knudsen S; Moen K; Ruhwald M; Kromann I; Andersen P; Shattock RJ; Follmann F
    Lancet Infect Dis; 2019 Oct; 19(10):1091-1100. PubMed ID: 31416692
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens.
    Sharma SK; Roumanes D; Almudevar A; Mosmann TR; Pichichero ME
    Vaccine; 2013 Jun; 31(30):3090-7. PubMed ID: 23632305
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.
    Olafsdottir TA; Lingnau K; Nagy E; Jonsdottir I
    Infect Immun; 2012 Jan; 80(1):461-8. PubMed ID: 22025519
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of a bivalent protein-based vaccine candidate against invasive pneumococcal diseases based on novel pneumococcal surface protein A in combination with pneumococcal histidine triad protein D.
    Afshari E; Ahangari Cohan R; Shams Nosrati MS; Mousavi SF
    Front Immunol; 2023; 14():1187773. PubMed ID: 37680628
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice.
    Khan MN; Pichichero ME
    Infect Immun; 2013 Oct; 81(10):3781-92. PubMed ID: 23897609
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage.
    Holmlund E; Quiambao B; Ollgren J; Jaakkola T; Neyt C; Poolman J; Nohynek H; Käyhty H
    Clin Vaccine Immunol; 2009 Jun; 16(6):916-23. PubMed ID: 19403781
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial.
    Geldenhuys H; Mearns H; Miles DJ; Tameris M; Hokey D; Shi Z; Bennett S; Andersen P; Kromann I; Hoff ST; Hanekom WA; Mahomed H; Hatherill M; Scriba TJ; ; van Rooyen M; Bruce McClain J; Ryall R; de Bruyn G;
    Vaccine; 2015 Jul; 33(30):3592-9. PubMed ID: 26048780
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proprietary arabinogalactan extract increases antibody response to the pneumonia vaccine: a randomized, double-blind, placebo-controlled, pilot study in healthy volunteers.
    Udani JK; Singh BB; Barrett ML; Singh VJ
    Nutr J; 2010 Aug; 9():32. PubMed ID: 20796315
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial.
    Leroux-Roels G; Marchant A; Levy J; Van Damme P; Schwarz TF; Horsmans Y; Jilg W; Kremsner PG; Haelterman E; Clément F; Gabor JJ; Esen M; Hens A; Carletti I; Fissette L; Tavares Da Silva F; Burny W; Janssens M; Moris P; Didierlaurent AM; Van Der Most R; Garçon N; Van Belle P; Van Mechelen M
    Clin Immunol; 2016 Aug; 169():16-27. PubMed ID: 27236001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.